THURSDAY, Oct. 24, 2024 (HealthDay News) — Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says. People with type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer’s compared to patients taking sevenContinue Reading

WEDNESDAY, Oct. 23, 2024 (HealthDay News) — Women fighting breast cancer can relieve some of their chemotherapy “brain fog” through aerobic exercise, a new clinical trial in Canada suggests. Breast cancer patients on chemo who participated in a regular aerobics class reported that they felt sharper and had better qualityContinue Reading

FRIDAY, Oct. 18, 2024 (HealthDay News) — Depression can make it tougher for athletes to recover from a concussion, and vice versa, a new study finds. Student athletes who have both concussion and depression have significantly worse symptoms for both conditions, researchers reported recently in the journal Brain Research. What’sContinue Reading

MONDAY, Oct. 14, 2024 (HealthDay News) — A simple tweak in available vial sizes of the breakthrough Alzheimer’s drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims. About 6% of Leqembi (lecanemab) is discarded because patients are frequently prescribed doses lower than theContinue Reading

FRIDAY, Oct. 11, 2024 (HealthDay News) — This year, breakdancing joined the ranks of Olympic-caliber sports, with Japan’s B-girl Ami Yuasa and Canada’s B-boy Phil Wizard taking home the gold. Now doctors warn breakdancing shares something else with other major sports – the risk of serious overuse injury. Specifically, breakersContinue Reading